← Back to Search

Behavioural Intervention

K-Talk Intervention for HPV Vaccination

N/A

Recruiting

Led By Minjin Kim, PhD., RN

Research Sponsored by University of Cincinnati

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at baseline, 3-month, 6-month, and 12-month follow-up

Awards & highlights

No Placebo-Only Group

Summary

This trial will test if an AI chatbot + storytelling intervention can help Korean Americans aged 18-26 get vaccinated for HPV.

Who is the study for?

This trial is for Korean Americans aged 18 to 26 who live in the U.S., speak or read English, have not received an HPV vaccine, and use a mobile device. It's designed to see if a video and chatbot program can increase HPV vaccination rates.

What is being tested?

The study tests K-Talk, which combines storytelling videos and AI chatbot technology to encourage HPV vaccinations. Participants are split into four groups: one with both chatbot and storytelling, one with just the chatbot, one with only storytelling, and one receiving written information.

What are the potential side effects?

Since this trial focuses on educational interventions rather than medical treatments or drugs, there are no direct side effects from the interventions being tested.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at baseline, 3-month, 6-month, and 12-month follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at baseline, 3-month, 6-month, and 12-month follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline, 3-month, 6-month, and 12-month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Number of participants who completed 3 doses of HPV vaccines at 12-months

Number of participants who completed 3 doses of HPV vaccines at 6-months

Number of participants who received at least one dose of HPV vaccine at 12-month

+2 more

Secondary study objectives

Assessing Perceived Risk of HPV and Other STIs: A 17-Item Survey (on a 1-5 Likert scale)

Assessment of Intention to Receive HPV Vaccine: Two Items Self-Report

Assessment of Knowledge about HPV and HPV Vaccines: A 34-Item Survey (True/False/I don't know)

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups

Experimental Treatment

Active Control

Group I: Storytelling InterventionExperimental Treatment2 Interventions

After completing the pre-test survey, participants from all intervention groups will receive the written information. Subsequently, they will be randomly assigned to one of the intervention groups. The storytelling intervention group will only be exposed to periodic release of stories via email for 3 months.

Group II: K-Talk Intervention: Storytelling and AI ChatbotExperimental Treatment2 Interventions

After completing the pre-test survey, participants from all intervention groups will receive the written information. Subsequently, they will be randomly assigned to one of the intervention groups. The K-Talk group will receive a series of weekly storytelling videos, and access to the chatbot via the web-based platform KakaoTalk for 3 months.

Group III: K-Bot (AI Chatbot Intervention) InterventionExperimental Treatment2 Interventions

After completing the pre-test survey, participants from all intervention groups will receive the written information. Subsequently, they will be randomly assigned to one of the intervention groups. The K-Bot group will only interact with the chatbot via the web-based platform or KakaoTalk for 3 months.

Group IV: Written InformationActive Control1 Intervention

This group will only be exposed to written, didactic HPV education materials after the pre-test.

Do I qualify?Apply below to find out